In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
- PMID: 35815257
- PMCID: PMC9253962
- DOI: 10.15420/cfr.2022.08
In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
Abstract
Implementation of guideline-directed medical therapy for patients with heart failure is suboptimal. The use of guideline-directed medical therapy improves minimally after heart failure hospitalisation, despite this event clearly indicating increased risk of further hospitalisation and death. In-hospital initiation and titration of guideline-directed medical therapies is one potential strategy to fill these gaps in care, both in the acute vulnerable period after hospital discharge and in the long term. The purpose of this article is to review the knowledge gaps in best practices of in-hospital initiation and up-titration of guideline-directed medical therapies, the benefits and risks of in-hospital initiation and post-discharge focused titration of guideline-directed medical therapies, the recent literature evaluating these practices, and propose strategies to apply these principles to the care of patients with heart failure with reduced ejection fraction.
Keywords: Heart failure; guideline-directed medical therapy; in-hospital; initiation; titration.
Copyright © 2022, Radcliffe Cardiology.
Conflict of interest statement
Disclosure: ZLC received research funding from AstraZeneca and Cumberland Pharmaceuticals. JL received honoraria for consultation from Abbott, Alleviant, AstraZeneca, Boehringer Ingelheim, Boston Scientific, CVRx, Edwards Lifesciences, Merck and Vwave, and grant function from AstraZeneca, Volumetrix and Sensible Medical; honoraria for consultation/advisory committee participation from Bayer, scPharmaceuticals, Vifor Pharma, Amgen, Relpysa, Baxter; and served on the Clinical Events Committee for the Guide-HF trial for Abbott Pharmaceuticals and the Data Safety Monitoring Board for the Anthem trial by Liva Nova Pharmaceuticals. ASR is on the Cardiac Failure Review editorial board; this did not influence peer review. All other authors have no conflicts of interest to declare.
Figures
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD009889. doi: 10.1002/14651858.CD009889.pub2. Cochrane Database Syst Rev. 2015. PMID: 26689943 Free PMC article.
-
The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial.JACC Heart Fail. 2024 Apr;12(4):678-690. doi: 10.1016/j.jchf.2024.02.008. JACC Heart Fail. 2024. PMID: 38569821 Clinical Trial.
-
Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing, and titration of guideline-recommended medical therapy.Eur Heart J. 2025 Jul 1;46(25):2394-2405. doi: 10.1093/eurheartj/ehaf244. Eur Heart J. 2025. PMID: 40272103 Free PMC article.
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 May 22;5:CD012721. doi: 10.1002/14651858.CD012721.pub3. PMID: 29952095 Free PMC article. Updated.
Cited by
-
Guideline-directed medical therapy implementation during hospitalization for cardiogenic shock.ESC Heart Fail. 2025 Feb;12(1):60-70. doi: 10.1002/ehf2.14863. Epub 2024 Sep 26. ESC Heart Fail. 2025. PMID: 39327768 Free PMC article.
-
Statin therapy impact on Long-Term outcomes in acute heart Failure: Retrospective analysis of hospitalized patients.Int J Cardiol Heart Vasc. 2024 May 20;53:101431. doi: 10.1016/j.ijcha.2024.101431. eCollection 2024 Aug. Int J Cardiol Heart Vasc. 2024. PMID: 38826832 Free PMC article.
-
Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode.ESC Heart Fail. 2024 Apr;11(2):628-636. doi: 10.1002/ehf2.14647. Epub 2023 Dec 29. ESC Heart Fail. 2024. PMID: 38158630 Free PMC article. Review.
-
Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review.J Clin Med Res. 2024 Oct;16(10):449-464. doi: 10.14740/jocmr6033. Epub 2024 Oct 11. J Clin Med Res. 2024. PMID: 39544327 Free PMC article. Review.
-
Hospitalist Recognition and Treatment of Obesity in Inpatients: A Quality Improvement Cohort Study.J Brown Hosp Med. 2024 Apr 1;3(2):94545. doi: 10.56305/001c.94545. eCollection 2024. J Brown Hosp Med. 2024. PMID: 40026791 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources